Wang Junyuan Jerry
SEC CIK 2017749 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NUVB | Nuvation Bio Inc. | CEO, ANHEART THERAPEUTICS LTD, Dir | 3.87M | — | $162.9K | 5 | 2024-04-09 | 2024-11-11 |
Most active insiders at NUVB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hattersley Gary | CSO | — | $3.88M |
| 2 | Liu Dongfang | Chief MEDICAL Off | — | $1.87M |
| 3 | Wentworth Kerry | Chief REGULATORY Off | — | $1.47M |
| 4 | Hanley David C. | CHIEF TECHNICAL Ops | — | $1.43M |
| 5 | Markel Stacy | CHRO | — | $753.2K |
| 6 | Sauvage Philippe | CFO | — | $286.4K |
| 7 | Mashal Robert | Dir | $118.3K | — |
| 8 | Makunje Moses | SEE REMARKS | — | — |
Wang Junyuan Jerry made no open-market trades at NUVB in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-13 | 2024-11-11 | NUVB | Nuvation Bio Inc. | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD, Dir | S - Sale | $2.89 | -56.4K | 3.87M | -1% | -$162.9K | |
| DI | 2024-09-05 | 2024-09-04 | NUVB | Nuvation Bio Inc. | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD, Dir | C - Cnv Deriv | — | +1.70M | 2.25M | +308% | — |
| D | 2024-09-05 | 2024-09-04 | NUVB | Nuvation Bio Inc. | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD, Dir | C - Cnv Deriv | — | +2.54M | 3.92M | +184% | — |
| D | 2024-04-11 | 2024-04-09 | NUVB | Nuvation Bio Inc. | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD, Dir | A - Grant | $0.00 | +1.38M | 1.38M | New | $0 |
| DI | 2024-04-11 | 2024-04-09 | NUVB | Nuvation Bio Inc. | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD, Dir | A - Grant | $0.00 | +550.8K | 550.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations